XY gonadal dysgenesis

From Vero - Wikipedia
Jump to navigation Jump to search

Template:Redirect Template:Infobox medical condition

XY complete gonadal dysgenesis, also known as Swyer syndrome, is a condition resulting in a female phenotype in an individual with a 46,XY karyotype. Though they typically have normal vulvas,<ref name=":1" /> those affected typically have underdeveloped gonads, fibrous tissue termed "streak gonads", and without hormone replacement therapy, typically will not experience puberty. The cause is often, but not always, inactivation of the SRY gene, which is responsible for sexual differentiation. Pregnancy is sometimes possible in Swyer syndrome with assisted reproductive technology, and, in at least one case, without it.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref>

The syndrome was named after Gerald Swyer, an endocrinologist based at London's University College Hospital, who first reported two cases in 1955.<ref name="pmid13250193">Template:Cite journal</ref>

Signs and symptoms

Those with Swyer syndrome develop phenotypes typical of females and nonfunctional gonads. Individuals are most commonly diagnosed during adolescence after puberty fails to occur.<ref>Template:Cite web</ref>

The consequences of Swyer syndrome without treatment:

Genetics

Genetic associations of Swyer syndrome include:

Type OMIM Gene Locus
46,XY gonadal dysgenesis, complete, SRY-related Template:OMIM SRY Yp11.3
46,XY gonadal dysgenesis, complete or partial, DHH-related Template:OMIM DHH 12q13.1
46,XY gonadal dysgenesis, complete or partial, with or without adrenal failure Template:OMIM NR5A1 9q33
46,XY gonadal dysgenesis, complete, CBX2-related Template:OMIM CBX2 17q25
46,XY gonadal dysgenesis, complete or partial, with 9p24.3 deletion Template:OMIM DMRT1/2 9p24.3

Seven other genes have been identified with probable associations that are as yet less clearly understood.<ref>Template:Cite journal</ref>

Pure gonadal dysgenesis

There are several forms of gonadal dysgenesis. The term "pure gonadal dysgenesis" (PGD) has been used to describe conditions with normal sets of sex chromosomes (e.g., 46,XX or 46,XY), as opposed to those whose gonadal dysgenesis results from missing all or part of the second sex chromosome. The latter group includes those with Turner syndrome (i.e., 45,X) and its variants, as well as those with mixed gonadal dysgenesis and a mixture of cell lines, some containing a Y chromosome (e.g., 46,XY/45,X).

Thus Swyer syndrome is referred to as PGD, 46,XY, and XX gonadal dysgenesis as PGD, 46,XX.<ref>Template:Cite journal</ref> People with PGD have a normal karyotype but may have defects of a specific gene on a chromosome.

In 2007, a case was reported of a woman with 46,XY complete gonadal dysgenesis whose mother had a 46,XY karyotype in peripheral lymphocytes, 80% 46,XY and 20% 45,X in cultured skin fibroblasts, and largely 46,XY karyotype in the ovary.<ref>Template:Cite journal</ref>

Pathogenesis

The first known step of sexual differentiation of a male fetus is the development of testes. The early stages of testicular formation in the second month of gestation require the action of several genes, one of the earliest and most important of which is SRY: the sex-determining region of the Y chromosome.<ref>Template:Cite web</ref><ref>Template:Cite web</ref>

When such a gene is defective, the indifferent gonads fail to differentiate into testes in an XY fetus. Without testes, no testosterone or anti-Müllerian hormone (AMH) is produced. Without testosterone, the Wolffian ducts fail to develop, so no internal male organs are formed. Also, the lack of testosterone means that no dihydrotestosterone is formed and consequently the external genitalia fail to virilize, resulting in a normal vulva.<ref>Template:Cite journal</ref> Without AMH, the Müllerian ducts develop into normal internal female organs (uterus, fallopian tubes, cervix, vagina).<ref>Template:Citation</ref>

Diagnosis

Due to the inability of the streak gonads to produce sex hormones (both estrogens and androgens), most of the secondary sex characteristics do not develop. This is especially true of estrogenic changes such as breast development, widening of the pelvis and hips, and menstrual periods.<ref>Template:Cite journal</ref> As the adrenal glands can make limited amounts of androgens and are not affected by this syndrome, most of these persons will develop pubic hair, though it often remains sparse.<ref>Template:Cite journal</ref>

Evaluation of delayed puberty usually reveals elevation of gonadotropins, indicating that the pituitary is providing the signal for puberty but the gonads are failing to respond. The next steps of the evaluation usually include checking a karyotype and imaging of the pelvis.<ref>Template:Cite journal</ref> The karyotype reveals XY chromosomes and the imaging demonstrates the presence of a uterus but no ovaries (the streak gonads are not usually seen by most imaging). Although an XY karyotype can also indicate a person with complete androgen insensitivity syndrome, the absence of breasts, and the presence of a uterus and pubic hair exclude the possibility. At this point it is usually possible for a physician to make a diagnosis of Swyer syndrome.<ref>Template:Cite web</ref>

Swyer syndrome represents one phenotypic result of a failure of the gonads to develop properly, and hence is part of a class of conditions termed gonadal dysgenesis. There are many forms of gonadal dysgenesis.<ref>Template:Cite journal</ref>

Swyer syndrome is an example of a condition in which an externally unambiguous female body carries dysgenetic, atypical, or abnormal gonads.<ref>Template:Cite journal</ref> Other examples include complete androgen insensitivity syndrome, partial X chromosome deletions, lipoid congenital adrenal hyperplasia, and Turner syndrome.<ref>Template:Citation</ref>

Treatment

Upon diagnosis, estrogen and progestogen therapy is typically commenced, promoting the development of female characteristics.

Hormone replacement therapy can also reduce the likelihood of osteoporosis.<ref name=":1">Template:Cite web</ref>

Epidemiology

A 2017 study estimated that the incidence of Swyer syndrome is approximately 1 in 100,000 females.<ref>Template:Cite journal</ref> Fewer than 100 cases have been reported as of 2018. There are extremely rare instances of familial Swyer syndrome.<ref name="pmid29069951">Template:Cite journal</ref> <ref>Template:Cite web</ref>

People with XY gonadal dysgenesis

See also

References

Template:Reflist

Further reading

Template:Medical resources Template:Congenital malformations of genital organs and urinary system Template:Extracellular ligand disorders Template:Transcription factor/coregulator deficiencies Template:Use dmy dates